Nuclear Imaging Equipment Market Top Players, Segments & Regional Trends By 2034

Straits Research released its highly anticipated report, “Global Nuclear Imaging Equipment Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 7.21 billion in 2025 and is anticipated to grow till USD 9.52 billion by 2034, growing at a CAGR of 3.18% from 2026-2034.

Market Dynamics

The nuclear imaging equipment market is driven by growing adoption of molecular imaging for early disease characterization, as clinicians increasingly rely on PET and SPECT systems to visualize metabolic shifts that are undetectable on anatomical imaging alone. However, market expansion is restrained by the limited availability of radiotracer production infrastructure in regions without dedicated radiopharmacy networks, which places operational constraints on facilities seeking to broaden their nuclear imaging services. Despite these challenges, the market presents a strong opportunity through the rapid advancement of targeted radioligand therapies, as clinical trials and treatment programs require high-precision imaging systems for patient selection, treatment planning, and therapeutic monitoring, creating new demand across hospitals and research institutions worldwide.

Market Highlights

• Product: Based on Product, the SPECT Imaging Systems segment dominated the market with a revenue share of 58.98%.
• Application: Based on Application, the Oncology segment dominated the market with a revenue share of 50.12%.
• End Use: Based on End Use, the Hospitals segment dominated the market with a revenue share of 53.24%.
• Regional Insights: North America held a dominant share of the global market, accounting for 43.78%.